E. Van Limbergen

620 total citations
26 papers, 372 citations indexed

About

E. Van Limbergen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, E. Van Limbergen has authored 26 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in E. Van Limbergen's work include Breast Cancer Treatment Studies (10 papers), BRCA gene mutations in cancer (4 papers) and Advanced Breast Cancer Therapies (3 papers). E. Van Limbergen is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), BRCA gene mutations in cancer (4 papers) and Advanced Breast Cancer Therapies (3 papers). E. Van Limbergen collaborates with scholars based in Belgium, Switzerland and France. E. Van Limbergen's co-authors include Anita Leys, Peter Stalmans, L. Vanuytsel, Emmanuel van der Schueren, W. Van den Bogaert, Patrick Neven, Hans Wildiers, Chantal Van Ongeval, Robert Paridaens and Ignace Vergote and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

E. Van Limbergen

26 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Van Limbergen Belgium 8 145 98 98 95 73 26 372
B Asselain France 11 133 0.9× 79 0.8× 122 1.2× 80 0.8× 92 1.3× 37 393
Howard Hsu United States 9 44 0.3× 105 1.1× 64 0.7× 97 1.0× 61 0.8× 11 326
Aaron Wagner United States 8 35 0.2× 56 0.6× 38 0.4× 19 0.2× 57 0.8× 22 225
Izaskun Valduvieco Spain 9 55 0.4× 82 0.8× 57 0.6× 35 0.4× 56 0.8× 41 271
Tosol Yu South Korea 9 42 0.3× 99 1.0× 137 1.4× 56 0.6× 67 0.9× 21 326
Luigia Nardone Italy 11 184 1.3× 67 0.7× 76 0.8× 119 1.3× 42 0.6× 18 308
Melek Tuğçe Yılmaz Türkiye 7 95 0.7× 210 2.1× 243 2.5× 19 0.2× 54 0.7× 27 365
Nam Kwon Lee South Korea 11 72 0.5× 93 0.9× 166 1.7× 167 1.8× 143 2.0× 34 396
Hiroyuki Kawakami Japan 11 48 0.3× 179 1.8× 205 2.1× 29 0.3× 184 2.5× 32 441
Douglas G. Gold United States 7 42 0.3× 137 1.4× 98 1.0× 28 0.3× 137 1.9× 10 323

Countries citing papers authored by E. Van Limbergen

Since Specialization
Citations

This map shows the geographic impact of E. Van Limbergen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Van Limbergen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Van Limbergen more than expected).

Fields of papers citing papers by E. Van Limbergen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Van Limbergen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Van Limbergen. The network helps show where E. Van Limbergen may publish in the future.

Co-authorship network of co-authors of E. Van Limbergen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Van Limbergen. A scholar is included among the top collaborators of E. Van Limbergen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Van Limbergen. E. Van Limbergen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berbée, Maaike, Ruud Houben, E. Van Limbergen, et al.. (2020). PO-1793: BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial. Radiotherapy and Oncology. 152. S1000–S1001. 1 indexed citations
2.
Pötter, Richard, Alina Sturdza, Lars Fokdal, et al.. (2019). Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study. International Journal of Radiation Oncology*Biology*Physics. 104(4). 895–902. 65 indexed citations
3.
Legius, Eric, Griet Van Buggenhout, Giuseppe Floris, et al.. (2019). Abstract P5-09-05: Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations. Cancer Research. 79(4_Supplement). P5–9. 1 indexed citations
4.
Habr‐Gama, Angelita, José G. Guillem, Krzysztof Bujko, et al.. (2018). EP-1472: Microscopic extension of residual rectal tumor mass post-neoadjuvant chemoradiation: a meta-analysis. Radiotherapy and Oncology. 127. S799–S799. 1 indexed citations
5.
Peremans, Lieve, et al.. (2016). Richtlijn voor goede medische praktijkvoering. 45(4). 150–169. 1 indexed citations
6.
Brouckaert, Olivier, Annouschka Laenen, Adelheid Soubry, et al.. (2016). Abstract P6-09-11: Independent prognostic value of age depends on breast cancer subtype. Cancer Research. 76(4_Supplement). P6–9. 1 indexed citations
7.
Brouckaert, Olivier, Arjan H. Schoneveld, Carla Truyers, et al.. (2013). Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers. Annals of Oncology. 24(7). 1847–1852. 27 indexed citations
8.
Brouckaert, Olivier, Ben Van Calster, Robert Paridaens, et al.. (2012). Abstract P6-07-19: Prognostic relevance of PR and detection mode in Luminal Her-2 negative breast cancer. Cancer Research. 72(24_Supplement). P6–7. 1 indexed citations
9.
Brouckaert, Olivier, Annouschka Laenen, Joke Vanderhaegen, et al.. (2012). Abstract P6-07-29: Independent prognostic value of age depends on breast cancer subtype. Cancer Research. 72(24_Supplement). P6–7. 2 indexed citations
10.
Tanderup, Kari, Jacob Christian Lindegaard, Christian Kirisits, et al.. (2011). 54 speaker EMBRACE UPDATE. Radiotherapy and Oncology. 99. S22–S23. 5 indexed citations
11.
Wildiers, Hans, Patrick Neven, Marie‐Rose Christiaens, et al.. (2010). Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer. Annals of Oncology. 22(3). 588–594. 22 indexed citations
12.
Mottaghy, Felix M., Sarah Ceyssens, Walter De Wever, et al.. (2010). Additional Value of PET-CT in Staging of Clinical Stage IIB and III Breast Cancer. The Breast Journal. 16(6). 617–624. 76 indexed citations
13.
Brouckaert, Olivier, V. Van Belle, Sabine Van Huffel, et al.. (2009). Biology and prognosis by age of primary operable breast cancer.. Cancer Research. 69(2_Supplement). 2082–2082. 3 indexed citations
14.
Wildiers, Hans, Patrick Neven, Frédéric Amant, et al.. (2009). Multicenter phase II study of neoadjuvant capecitabine (X), docetaxel (T) ± trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): final analysis.. Cancer Research. 69(2_Supplement). 5115–5115. 3 indexed citations
15.
Stroobants, Sigrid, et al.. (2008). Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB. International Journal of Gynecological Cancer. 18(4). 723–729. 3 indexed citations
16.
Poppel, Hendrik Van, Yolande Lievens, E. Van Limbergen, & Luc Baert. (2000). Brachytherapy with Iridium–192 for Bladder Cancer. European Urology. 37(5). 605–608. 8 indexed citations
17.
Limbergen, E. Van, et al.. (1999). Radiation-associated choroidal neovasculopathy, exudative detachment and neovascular glaucoma. A case report.. PubMed. 274. 51–6. 1 indexed citations
18.
19.
20.
Schueren, Emmanuel van der, W. Van den Bogaert, L. Vanuytsel, & E. Van Limbergen. (1990). Radiotherapy by multiple fractions per day (mfd) in head and neck cancer: Acute reactions of skin and mucosa. International Journal of Radiation Oncology*Biology*Physics. 19(2). 301–311. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Asselain Breakdown of academic impact, for papers by Howard Hsu Breakdown of academic impact, for papers by Aaron Wagner Breakdown of academic impact, for papers by Izaskun Valduvieco Breakdown of academic impact, for papers by Tosol Yu Breakdown of academic impact, for papers by Luigia Nardone Breakdown of academic impact, for papers by Melek Tuğçe Yılmaz Breakdown of academic impact, for papers by Nam Kwon Lee Breakdown of academic impact, for papers by Hiroyuki Kawakami Breakdown of academic impact, for papers by Douglas G. Gold
Rankless by CCL
2026